Plus, news about Saol Therapeutics, Eisai, Takeda's Vonvendi, Junshi Biosciences, Belite Bio, Integra Therapeutics, Novonesis and Novo Nordisk:
📊 BridgeBio’s positive hypoparathyroidism results: The biotech’s encaleret normalized urine ...
↧